An official website of the United States government Here's how you know

The .gov means it's official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you're on a federal government site.

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 012250
Company: HOSPIRA

Products on NDA 012250

Drug Name	Active Ingredients	Strength	Dosage Form/Route	Marketing Status	TE Code	RLD	RS
CARBOCAINE	MEPIVACAINE HYDROCHLORIDE	1%	INJECTABLE;INJECTION	Discontinued	None	Yes	No
CARBOCAINE	MEPIVACAINE HYDROCHLORIDE	2%	INJECTABLE;INJECTION	Discontinued	None	Yes	No
CARBOCAINE	MEPIVACAINE HYDROCHLORIDE	1.5%	INJECTABLE;INJECTION	Discontinued	None	Yes	No

Approval Date(s) and History, Letters, Labels, Reviews for NDA 012250

Original Approvals or Tentative Approvals

Action Date	Submission	Action Type	Submission Classification	Review Priority; Orphan Status	Letters, Reviews, Labels, Patient Package Insert	Notes	Url
05/17/1960	ORIG-1	Approval	Type 3 - New Dosage Form	PRIORITY		Label is not available on this site.

Supplements

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
12/21/2023	SUPPL-40	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/012250s040lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/012250Orig1s040ltr.pdf
11/02/2018	SUPPL-37	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012250s037lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/012250Orig1s037Ltr.pdf
02/19/2010	SUPPL-33	Labeling-Package Insert	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/012250s033lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2010/012250s033ltr.pdf
09/28/2005	SUPPL-28	Labeling	Label (PDF) Letter (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/012250s028lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2005/012250s028ltr.pdf
01/31/2001	SUPPL-23	Manufacturing (CMC)-Control		Label is not available on this site.
03/11/1999	SUPPL-22	Labeling		Label is not available on this site.
05/21/1991	SUPPL-20	Manufacturing (CMC)		Label is not available on this site.
04/27/1999	SUPPL-19	Labeling		Label is not available on this site.
03/15/1985	SUPPL-18	Manufacturing (CMC)-Control		Label is not available on this site.
03/30/1984	SUPPL-17	Manufacturing (CMC)-Packaging		Label is not available on this site.
01/29/1987	SUPPL-16	Labeling		Label is not available on this site.
08/21/1981	SUPPL-15	Manufacturing (CMC)-Control		Label is not available on this site.
10/03/1980	SUPPL-14	Manufacturing (CMC)-Control		Label is not available on this site.
06/15/1978	SUPPL-13	Manufacturing (CMC)-Control		Label is not available on this site.
06/26/1979	SUPPL-12	Labeling		Label is not available on this site.
10/06/1976	SUPPL-10	Manufacturing (CMC)		Label is not available on this site.
10/28/1975	SUPPL-8	Labeling		Label is not available on this site.
04/15/1974	SUPPL-7	Labeling		Label is not available on this site.

Labels for NDA 012250

Action Date	Submission	Supplement Categories or Approval Type	Letters, Reviews, Labels, Patient Package Insert	Note	Url
12/21/2023	SUPPL-40	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2023/012250s040lbl.pdf
11/02/2018	SUPPL-37	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/012250s037lbl.pdf
02/19/2010	SUPPL-33	Labeling-Package Insert	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2010/012250s033lbl.pdf
09/28/2005	SUPPL-28	Labeling	Label (PDF)		https://www.accessdata.fda.gov/drugsatfda_docs/label/2005/012250s028lbl.pdf

Top